Russian Federation Law №61-FZ March 24, 2010 On Circulation of Medicines. Chapter 12 State Regulation of Prices for Medicinal Products for Medical Use - Article 61. State Registration of Manufacturers’ Maximum Ex-Works Prices for Vital and Essential Medicinal Products and Their Sale
Loading

Главная Documents Medical product approval Russian Federation Law №61-FZ March 24, 2010 On Circulation of Medicines. Chapter 12 State Regulation of Prices for Medicinal Products for Medical Use - Article 61. State Registration of Manufacturers’ Maximum Ex-Works Prices for Vital and Essential Medicinal Products and Their Sale
Russian Federation Law №61-FZ March 24, 2010 On Circulation of Medicines. Chapter 12 State Regulation of Prices for Medicinal Products for Medical Use - Article 61. State Registration of Manufacturers’ Maximum Ex-Works Prices for Vital and Essential Medicinal Products and Their Sale
Article Index
Russian Federation Law №61-FZ March 24, 2010 On Circulation of Medicines. Chapter 12 State Regulation of Prices for Medicinal Products for Medical Use
Article 60. State Regulation of Prices for Medicinal Products for Medical Use
Article 61. State Registration of Manufacturers’ Maximum Ex-Works Prices for Vital and Essential Medicinal Products and Their Sale
Article 62. State Register of Manufacturers’ Maximum Ex-Works Prices for Medicinal Products Included into the List of Vital and Essential Medicinal Products
Article 63. Determination by Executive Authorities of the Russian Federation Constituent Entities of Maximum Wholesale and Maximum Retail Mark-Ups to Actual Ex-Works Prices of Manufacturers of Medicinal Products for Medicinal Products for Medical Use
All Pages

 

Article 61. State Registration of Manufacturers’ Maximum Ex-Works Prices for Vital and Essential Medicinal Products and Their Sale

1. The determined by the manufacturers of the medicinal products maximum ex-works prices for the medicinal products included in the list of vital and essential medicinal products shall be subject to state registration.

2. The maximum ex-works price for vital and essential medicinal products proposed by a manufacturer is subject to state registration, unless it exceeds the price for the same medicinal product calculated in accordance with the methodology for determination of the manufacturers’ maximum ex-works prices for vital and essential medicinal products, which shall be approved in the order prescribed by the Government of the Russian Federation. This method assumes the calculation of weight-average actual ex-works price, weight-average actual import price of the medicinal product during the year, preceding the date of presenting of manufacturer's maximum ex-works price to state registration, for medicinal products being in circulation in the Russian Federation, and the calculation by the Russian manufacturers of medicinal products of costs associated to developing, manufacturing, sales, specifying by foreign manufacturers of medicinal products of minimal manufacturer's ex-works price for the medicinal product in manufacturer's country and other countries, where it is registered, with taking into account the costs associated to customs clearance (customs duty and customs fees for the customs clearance) and transport charges for medicinal products which did not come in circulation in the Russian Federation and originator medicines. (as amended by Federal Law of October 11, 2010, No. 271-FZ)

21. In calculation of maximum ex-works price the following shall be taken into account along to the data specified in Clause 2 of this Article:

1) regarding to Russian manufacturer – the price on analogous (by international non-proprietary name, certain dosage form and dosage rate) medicinal products, manufactured in the Russian Federation or in case of absence of such - the price on analogous foreign medicinal products being in civil circulation in the Russian Federation;
2) regarding to foreign manufacturer -  the price on analogous (by international non-proprietary name, certain dosage form and dosage rate) medicinal products being in civil circulation in the Russian Federation”; (clause 21 introduced by Federal Law of October 11, 2010, No. 271-FZ)

22. On the ground of the statement submitted up to October 1 of each year by the Russian manufacturer of medicinal products, included in the list of vital and the most important medicinal products, registered maximum ex-works price for the medicinal product in case of change of prices for raw materials, indirect costs, as well as estimated inflation on the base of the federal budget for the respective financial period and scheduled period, may be re-registered, but not more than ones per calendar year  in the order established by the Clauses 2 and 21 of this Article. (clause 22 introduced by Federal Law of October 11, 2010, No. 271-FZ)

3. It is prohibited to sell medicinal products included in the list of vital and essential medicinal products, the manufacturer’s maximum ex-works price for which have not been registered.

 



 
More Info